GSK PLC (GSK)
36.97
+0.09
(+0.24%)
USD |
NYSE |
Nov 04, 16:00
36.98
+0.01
(+0.03%)
After-Hours: 20:00
GSK Price to Book Value: 4.025 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.014 |
| October 31, 2024 | 4.001 |
| October 30, 2024 | 4.028 |
| October 29, 2024 | 4.154 |
| October 28, 2024 | 4.123 |
| October 25, 2024 | 4.084 |
| October 24, 2024 | 4.108 |
| October 23, 2024 | 4.134 |
| October 22, 2024 | 4.136 |
| October 21, 2024 | 4.153 |
| October 18, 2024 | 4.196 |
| October 17, 2024 | 4.240 |
| October 16, 2024 | 4.268 |
| October 15, 2024 | 4.240 |
| October 14, 2024 | 4.259 |
| October 11, 2024 | 4.226 |
| October 10, 2024 | 4.268 |
| October 09, 2024 | 4.380 |
| October 08, 2024 | 4.138 |
| October 07, 2024 | 4.204 |
| October 04, 2024 | 4.225 |
| October 03, 2024 | 4.176 |
| October 02, 2024 | 4.294 |
| October 01, 2024 | 4.386 |
| September 30, 2024 | 4.449 |
| Date | Value |
|---|---|
| September 27, 2024 | 4.568 |
| September 26, 2024 | 4.589 |
| September 25, 2024 | 4.551 |
| September 24, 2024 | 4.598 |
| September 23, 2024 | 4.584 |
| September 20, 2024 | 4.578 |
| September 19, 2024 | 4.670 |
| September 18, 2024 | 4.760 |
| September 17, 2024 | 4.775 |
| September 16, 2024 | 4.886 |
| September 13, 2024 | 4.826 |
| September 12, 2024 | 4.837 |
| September 11, 2024 | 4.911 |
| September 10, 2024 | 4.948 |
| September 09, 2024 | 4.930 |
| September 06, 2024 | 4.900 |
| September 05, 2024 | 4.839 |
| September 04, 2024 | 4.966 |
| September 03, 2024 | 4.874 |
| August 30, 2024 | 4.926 |
| August 29, 2024 | 4.908 |
| August 28, 2024 | 4.925 |
| August 27, 2024 | 4.954 |
| August 26, 2024 | 4.773 |
| August 23, 2024 | 4.783 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.935
Minimum
Sep 27 2022
7.596
Maximum
Dec 06 2022
4.710
Average
4.560
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 5.605 |
| Pfizer Inc | 1.794 |
| Adaptimmune Therapeutics PLC | 2.190 |
| TC BioPharm (Holdings) PLC | 0.5075 |
| Moderna Inc | 1.758 |
Price to Book Value Related Metrics
| PE Ratio | 24.04 |
| PS Ratio | 1.920 |
| Price to Free Cash Flow | 12.60 |
| Price | 36.97 |
| Earnings Yield | 4.16% |
| Market Cap | 75.43B |
| Operating PE Ratio | 13.45 |
| Normalized PE Ratio | 20.51 |